GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » Total Assets

GemPharmatech Co (SHSE:688046) Total Assets : ¥2,651.0 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co Total Assets?

GemPharmatech Co's Total Assets for the quarter that ended in Mar. 2025 was ¥2,651.0 Mil.

During the past 12 months, GemPharmatech Co's average Total Assets Growth Rate was 7.50% per year. During the past 3 years, the average Total Assets Growth Rate was 36.20% per year. During the past 5 years, the average Total Assets Growth Rate was 59.00% per year.

During the past 7 years, GemPharmatech Co's highest 3-Year average Total Assets Growth Rate was 121.00%. The lowest was 36.20%. And the median was 76.05%.

Total Assets is connected with ROA %. GemPharmatech Co's annualized ROA % for the quarter that ended in Mar. 2025 was 4.59%. Total Assets is also linked to Revenue through Asset Turnover. GemPharmatech Co's Asset Turnover for the quarter that ended in Mar. 2025 was 0.07.


GemPharmatech Co Total Assets Historical Data

The historical data trend for GemPharmatech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co Total Assets Chart

GemPharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial 883.19 1,054.41 2,253.72 2,577.59 2,572.65

GemPharmatech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,559.43 2,614.19 2,533.54 2,572.65 2,650.96

GemPharmatech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

GemPharmatech Co's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=2134.726+437.919
=2,572.6

GemPharmatech Co's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (Q: Mar. 2025 )+Total Liabilities (Q: Mar. 2025 )
=2161.921+489.043
=2,651.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GemPharmatech Co  (SHSE:688046) Total Assets Explanation

Total Assets is connected with ROA %.

GemPharmatech Co's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=119.92/( (2572.645+2650.964)/ 2 )
=119.92/2611.8045
=4.59 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

GemPharmatech Co's Asset Turnover for the quarter that ended in Mar. 2025 is

Asset Turnover
=Revenue (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=170.856/( (2572.645+2650.964)/ 2 )
=170.856/2611.8045
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

GemPharmatech Co Total Assets Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


GemPharmatech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032
GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co Headlines

No Headlines